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1152Objectives:An IgG and granulocyte-activating immune response with secondary dystrophic calcification might
be the reason glutaraldehyde (GA)-fixed xenograft valves fail, especially in young patients, who are more
immunocompetent than the elderly. Titanium nanocoating on GA-fixed bovine pericardium was tested for its
ability to prevent major immunoreactions.
Methods: The immune activity of platelets from GA-fixed bovine pericardium with different treatment proce-
dures was evaluated using the blood from 5 human donors: group I (n ¼ 5), GA fixed as the control; group 2
(n¼ 5), detoxified with 10% citric acid; group 3 (n¼ 5), 10% citric acid, aldehyde-dehydrogenase, and a phys-
ical plasma treatment; and group 4 (n ¼ 5), treated the same as group 3, but with an additional titanium coat 30
nm in thickness. Titanium deposition was visualized using scanning electron microscopy. IgG deposits (iC3b)
were shown by immunostaining and documented as colored pixels (red). The pixels were evaluated electroni-
cally. Attracted granulocytes (polymorphonuclear leukocytes) were counted in front of the titanium-coated
surface.
Results: IC3b deposits and polymorphonuclear leukocytes within control group 1 were defined as 100%; in
group 2, iC3b was 149%  34% and polymorphonuclear leukocytes were 89%, in group 3, IC3b was 102%
 24% and polymorphonuclear leukocytes were 47%; and in group 4, IC3b had decreased to 38.49%
 21% (P<.05) and polymorphonuclear leukocyte activation had decreased to 6.3% (P  .01).
Conclusions: Titanium coating significantly reduced the iC3b and granulocyte activating immune response of
GA-fixed pericardium. Therefore, it might prevent relevant immunorejection and increase the durability of
GA-fixed bioprosthetic heart valves. (J Thorac Cardiovasc Surg 2012;143:1152-9)Xenograft implantation is a common and excepted proce-
dure, especially whenvalves are replaced with bioprosthetic
heart valves, which are probably the best choice because of
their excellent function and the absence of a need for long-
term anticoagulants.1 In contrast, mechanical heart valves
have an approximate 50% risk of significant complications
with anticoagulant administration for 25 years.2,3
Glutaraldehyde (GA)-cross-linked valves do not require
coagulation therapy but have limited durability.2 They can
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The Journal of Thoracic and Cardiovascular Surinvestigators believe that the GA process leads to calcifica-
tion and failure of the valves owing to chemical processes
(free aldehyde groups with phospholipids).4 Others are con-
vinced that the main breakdown of GA-fixed valves is
caused by an immunologic response.1,3,5-7 It was shown
in a young animal model that GA-fixed xenograft valves un-
dergo rejection and inflammation that correlated with
calcification.6
Avalve breakdown can occur very soon in young patients
with a strong immune system (<5 years3,5). In patients older
than 70 years with a minor immune response, bioprosthetic
valves function well for more than 10 years.1 Xenogenic or-
gan transplantation stimulates a very aggressive form of
humoral and cellular immune rejection with tissue infiltra-
tion by lymphocytes and monocytes.8 Although the immu-
nologic lymphocyte and monocyte response could be
decreased by decellularization or GA fixation, the granulo-
cyte recruitment in decellularized xenografts and GA-fixed
heart valves was not influenced at all.9 The residual immu-
nostimulatory activity of decellularized porcine vascular
tissue toward polymorphonuclear (PNM) leukocytes ob-
served in vitro10,11 correlated with in vivo findings ofgery c May 2012
Abbreviations and Acronyms
GA ¼ glutaraldehyde
PBS ¼ phosphate-buffered saline
PMN ¼ polymorphonuclear
PACVD ¼ plasma-assisted chemical vapor
deposition
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xenografts mainly showed PMN cells and granulocyte
recruitment.9,12,13
Thus, our interest was to evaluate whether detoxification
and the new method of nanocoating with titanium13,14
would reduce the granulocyte-activating immune response
against GA cross-linked bovine pericardium. The immune
activity of platelets from GA-fixed bovine pericardium
treated with different procedures, including nanocoating
with titanium, was tested in contact with blood samples
from human donors. Titanium deposition was visualized us-
ing scanning electronic microscopy. IgG deposits (iC3b)
were demonstrated by immunostaining and documented
as colored pixels (red). The pixels were evaluated electron-
ically, and the attracted granulocytes (PMN leukocytes)
were counted in front of the blood-contacting collagen
surface.
MATERIALS AND METHODS
GA-Fixed Bovine Pericardium
Genuine bovine pericardiumwas fixedwith 0.25%GA solution at room
temperature for at least 24 hours. Circular platelets 9 mm in diameter were
cut out and sorted by weight. Platelets with a weight of 90 to 100 mg were
selected to minimize the influence of different masses on the test results.
Detoxification
Detoxification was performed using 10% citric acid (CA10%) as re-
ported previously.14-17 In brief, detoxification was performed by
incubating the platelets with 50 mL CA10%/platelet for 30 minutes.
Subsequently, the platelets were rinsed twice with 30 mL phosphate-
buffered saline (PBS) solution (Invitrogen, Carlsbad, Calif) for 10 minutes
to re-establish a neutral pH. Detoxification was also performed using alde-
hyde- dehydrogenase and buffer solution from a commercially available kit
(Enzymatic BioAnalysis; R-Biopharm, Darmstadt, Germany). Platelets
from the pericardium were incubated in a 24-well plate with 1-mL enzyme
solution each for 24 hours. Additionally, detoxification was achieved by
plasma deposition for titanium as described below.
Dehydration
Before performing a plasma-assisted chemical vapor deposition
(PACVD) process, the biologic material was dehydrated. The extraction
of water was performed under a low pressure of 3.8 3 1010 Pa in a slow
drying process for 3 hours at 32C.
Plasma Deposition for Titanium (PACVD)
PACVD with the gaseous precursor tetrakisdimethyl-amidotitanium
(Ti[N(CH3)2]4) was applied at a low pressure of 3.83 10
10 Pa and temper-
atures of 30 to 35C.The Journal of Thoracic and CarThe precursor was deconstructed and precipitated on the plasma-
activated collagen surface with energy supplied by a high alternating cur-
rent in a vacuum chamber. The carbon atoms that are bonded with titanium
can then generate paired electron bindings with carbon atoms of other li-
gands that have titanium bindings and with the carbon atoms of the colla-
gen. Thus, titanium is irremovably bound to collagen in an extremely thin
coating of approximate 30 nm of collagen. The detailed procedure descrip-
tion had been previously reported.14,18-20
Scanning Electron Microscopy
Platelets from the pericardium (n ¼ 4 3 5) were examined using scan-
ning electron microscopy after GA fixation, before and after drying, after
titanium coating, and after hydration and swelling. The probes were eval-
uated using scanning electron microscopy under a magnification of 50003
(Philips Electron Microscope EM 400 at 60 kV; Royal Philips Electronics,
Amsterdam, The Netherlands) (Figure 1).Blood Sampling, Plasma Preparation, and PMN
Leukocyte Isolation
Venous blood was collected from 5 healthy adult volunteers (3 women
and 2 men; mean age, 32  10.2 years) who were not taking any medica-
tions and who gave informed consent. The study was approved by the eth-
ical committee of the Medical University of Vienna. Whole blood was
anticoagulated with 5 IU/mL heparin and centrifuged at 2000 g for 15 min-
utes to obtain plasma. Human PMN leukocytes were retrieved from ethyl-
enediaminetetraacetic acid-anticoagulated venous blood by lysing 1 mL
blood with 5 mL 0.9% (wt/vol) ammonium chloride for 15 minutes at
4C, followed by centrifugation at 160 g and 4C for 10 minutes.21 The su-
pernatant was discarded and the cell pellet washed three times with PBS.
The cells were subsequently resuspended in Roswell Park Memorial Insti-
tute 1640 medium (BioWhittaker, Verbiers, Belgium) to a final concentra-
tion of 5000/mL and immediately used for the experiments. The cell
suspensions constituted 84.4%  3.1% PMN leukocytes, 11.6% 
2.7% lymphocytes, and 3.5% 1.6%monocytes. The platelet contamina-
tion was less than 0.1 platelet per PMN leukocytes.Adsorption of Plasma Proteins and Complement to
Tissue Specimens
The tissue specimens were incubated with 20% heparinized plasma
(diluted in PBS containing 0.15 mmol/L Ca2þ and 0.5 mmol/L Mg2þ) on
a rocking platform for 5 hours each at 37C.22,23
At the end of the incubations, the tissue specimens were removed, thor-
oughly rinsed with PBS, embedded in Tissue-Tec OCT compound, and fro-
zen in liquid nitrogen. Cryostat sections, 20 mm thick, were used for
histologic evaluation and for performing the PMN leukocyte/matrix
experiments.
Granulocyte Experiments
The plasma used to pretreat the tissue samples and granulocytes was ob-
tained from 5 donors for all groups. The tissue specimens (0.5 3 0.5 cm)
were either incubated or left untreated. The cryostat sections were incu-
bated with 5000 PMN leukocytes/mL for 15 minutes in a humidifieddiovascular Surgery c Volume 143, Number 5 1153
FIGURE 1. A, Scanning electron microscopy of glutaraldehyde (GA)-fixed pericardiumwith a magnification of 50003; B, GA-fixed and dehydrated peri-
cardium; and C, GA-fixed and dehydrated and titanized pericardium, with complete covering of surface by titanium. D, Rehydrated and swollen titanized
pericardium with a fractured titanium coat and grooves.
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because it had proved to be optimal for demonstrating PMN leukocyte ad-
hesion in vitro.
At the end of the incubation time, the PMN leukocyte suspensions were
aspirated.After standardized rinsingwith PBS (23 5minutes) in a chamber
with a flow of 500 mL/min samples were fixed with cold methanol (20C)
for 5 minutes. The samples were washed again with PBS (3 3 5 minutes)
and blocked with 2% bovine serum albumin in PBS for 1 hour. The spec-
imens were then incubated with either mouse anti-human iC3b (monoclo-
nal mouse IgG, 1:100; Quidel, San Diego, Calif) or mouse anti-human
CD11b (monoclonal mouse IgG, clone BEAR 1, 1:200; Beckman Coulter,
Fullerton, Calif), and rabbit anti-human CD45. Incubation with the primary
antibodies was followed by Alexa 488-conjugated goat anti-rabbit IgG
(1:1000; Molecular Probes, Eugene, Ore) and Alexa 546-conjugated goat
anti-mouse IgG (1:1000, Molecular Probes). Negative control sections
were incubated in parallel with omission of the first antibody. The samples
were mounted with Pro-Long Antifade Plus mounting medium (Molecular
Probes) and sealedwith glass coverslips. Adhesion of contaminatingmono-
cytes was excluded by staining with rabbit anti-human CD14 (polyclonal
rabbit IgG, 1:50; Santa Cruz Biotechnology, Santa Cruz, Calif) and Alexa
488-conjugated goat anti-rabbit IgG (1:1000;Molecular Probes) and show-
ing a yellow to green color in opposite to the red granulocytes.LASER SCANNING MICROSCOPY
Fixation of complement (iC3b) and PMN leukocyte ad-
hesion and activation on the matrix specimens was docu-
mented with a laser scanning microscopy 510 Meta laser1154 The Journal of Thoracic and Cardiovascular Surscanning microscope (Carl Zeiss, Jena, Germany). Scan-
ning was performed using the multitrack and bidirectional
scan mode. Negative controls showed no significant detec-
tion of Alexa 488 or Alexa 546 fluorophores.
QUANTIFICATION OF IC3B DEPOSITS AND PMN
LEUKOCYTES
IgG deposits (IC3b) were visualized using immune stain-
ing as described and digitized on histologic slices with
a magnification of 403. IC3b deposits were shown as red
pixels (Figure 2, E). Quantification was done using
custom-made image analysis software by counting the pre-
viously color-filtered pixels within a defined length of the
blood-contacting surface of 100 mm. To avoid misinterpre-
tation, the blood contact surface within that area had to be in
a straight line, not accepting any curves. Three samples
from each slice were taken in random order to calculate
a mean pixel value. Figure 2, E and F, demonstrated the
principle of iC3b quantification with marking the iC3b-
related red pixels (Figure 2, E) and deleting the counted
pixels (white) as a control (Figure 2, F).
PMN leukocyte quantification was performed by count-
ing the activated granulocytes near the blood-contacting
surface of the pericardium within an area of 250 3 250gery c May 2012
FIGURE 2. Immunostaining of iC3b deposits on (A) glutaraldehyde (GA)-fixed pericardium; (B) GA-fixed pericardium with 10% citric acid (CA10%);
and (C) GA-fixed pericardium with CA10%, aldehyde-dehydrogenase, and plasma treatment, D is similar to C but additionally with a titanium coating.
D and E, Principle of iC3b quantification with marking of the iC3b-related red pixels (see ‘‘Materials andMethods’’ section) and deleting the counted pixels
(white) for control (F).
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were taken for statistical analysis (Figure 3).
Statistical Analysis
The data are presented as the mean standard deviation.
For comparison between groups and of paired samples,
a Wilcoxon signed-rank test was applied. Differences
were considered significant at P  .05. All statistical calcu-
lations were performed using the software Winstat, version
3.0 (Kalmia, Cambridge, Mass).The Journal of Thoracic and CarRESULTS
Scanning Electron Microscopy
The images of the GA-fixed pericardium showed a fili-
gree net-like structure (Figure 1, A) which partially disap-
peared after drying (Figure 1, B). The images of the
titanium-coated pericardium showed an overall covered
surface (Figure 1, C) in a dry state. After rehydration
of the titanium-coated pericardium, however, the material
swelled, and the titanium coat burst, showing distinct
grooves (Figure 1, D). These structures most likely arosediovascular Surgery c Volume 143, Number 5 1155
FIGURE 3. Titanium coating of glutaraldehyde (GA)-fixed pericardium
in group 4 reduced the immune reaction of iC3b apposition on the collagen
surface to 38.49% (P<.043). Group 3 was treated with 10% citric acid
(CA10%), aldehyde-dehydrogenase, and a physical plasma without tita-
nium. These findings indicate that titanization of blood-contacting surfaces
might significantly reduce the immunologic response to iC3b (apposition
of iC3b in group 4 might be even<38% without CA10% application).
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quently the breaking of the previously solid titanium
coating. These results demonstrated that the titanium
coating in Figure 1, D, does not completely cover the
collagen.IC3b Deposits
The IC3b deposits within control group 1 of GA-fixed
pericardium were evaluated by pixel counting. The samples
rendered 4931, 6014, 2263, 2267, and 4316 pixels (total
3958.2  1812.1). This number was defined as 100%
(Figures 2, A, and 3).
In group 2, the number of pixels in the five samples was
7199 (146.0%), 8324 (138.4%), 2433 (107.5%), 4143
(182.8%), and 7494 (173.6%), and the total number of
iC3b pixels had increased to 5918  2778 (149.6% 
34.5%; Figures 2, B, and 3).
In group 3, the number of pixels of IC3b in the five sam-
ples was 4909 (99.5%), 5531 (91.9%), 1703 (75.3%), 2974
(131.2%), and 4839 (112.1%), indicating that IC3b was
roughly maintained, with a total of 3991.2  1746.4 pixels
(102.0%  24.3%; P<.22; Figures 2, C, and 3).
In group 4 (Figures 2, D, and 3), the number of pixels in
the five samples was 1653 (33.5%), 1056 (17.6%), 1265
(55.9%), 1348 (59.5%), 1123 (26.1%), indicating that
the total number of IC3b on the titanium-coated pericar-
dium was significantly decreased to 1289  132.6 pixels
(38.4%  21.06%; P<.043).PMN Leukocytes Versus Granulocytes
Quantification of the PMN leukocytes directly attached
to the blood-contacting surface of the pericardium is diffi-
cult, because the cells overlap and therefore were not able1156 The Journal of Thoracic and Cardiovascular Surto be discriminated. However, as shown in Figure 4, B, the
number of directly attached PNM leukocytes decreased
from group 1 to group 4. Activated PNM leukocytes
(red) were fixed to the glass slides in front of the pericar-
dium and therefore were easy to count (the yellow-green
cells [mononuclear cells] were excluded from the cell
count).
In the control group of GA-fixed pericardium, the num-
ber of granulocytes was 5960, 5633, 5712, 1467, 5585 in
the 5 samples, for a total 4879  1909 granulocytes
counted, defined as 100% (Figures 4 and 5).
In group 2, the PMN leukocytes had decreased to 4545,
4717, 3367, 5300, and 3822 in the 5 samples (total of
4350  762 granulocytes [89%]; Figures 4 and 5).
In group 3, the PMN leukocytes had decreased to 3120,
829, 1046, 5511, and 1015 in the 5 samples (total 2304 
2023 granulocytes [47%]; Figures 4 and 5).
In group 4, the PMN leukocytes (Figures 4 and 5) had
decreased to 220, 400, 200, and 436 (mean, 314  121
[6.3%]). Thus, the titanium-coated group 4 showed an im-
pressive decrease in PNM leukocytes to 6.3% (P  .01).
DISCUSSION
Nanocoating with titanium reduced the immunologic re-
sponse to GA-fixed bovine pericardium significantly to
IC3b deposits to 38.49% (P<.43) and PNM leukocyte ac-
tivation to 6.3% (P  .01).
Titanium Coating
PACVD for titanium is a coating technology (patent
EP0897997A1, Pfm Titanium GmbH, N€urnberg, Germany)
that transfers the so-called titanium-containing precursor
into the gas phase and transfers it into the reactor by a carrier
gas such as nitrogen gas under vacuum conditions.14,18,20
The carbon atoms of the deconstructed precursor bonded
with titanium are then able to generate paired electron
bindings to the carbon atoms of the collagen. Atomic
composition and binding could be shown by X-ray
photoelectron spectroscopy.14 The binding energy of tita-
nium is 460 electron volts and that of carbon is 290 electron
volts. The mechanical stability of the titanium coat seems
feasible and is dependent on an extremely thin (30 nm)
and nonfractured titanium layer.
Titanium Surface After Dehydration and
Rehydration
The scanning electron microscopic images of GA-fixed
pericardium showed a filigree net-like structure (Figure 1,
A) that disappeared after drying (Figure 1, B). These mor-
phologic changes, however, did not affect the mechanical
stability of the pericardium (previously investigated; own
unpublished data).
The images of the titanium-coated pericardium showed
overall covered surfaces on the dried samples (Figure 1, C).gery c May 2012
FIGURE 4. IC3b-activated polymorphonuclear (PNM) leukocytes on and in front of glutaraldehyde (GA)-fixed pericardium (group 1), GA-fixed pericar-
dium with 10% citric acid (CA10%) (group 2), GA-fixed pericardium with CA10%, aldehyde-dehydrogenase, and plasma treatment (group 3), group 4 is
similar to group 3 but additionally with a titanium coating. On these photographs of the titanium-coated group 4, PNM leukocytes are visible solely in sam-
ples 2 and 4. However, on average, they showed a decrease in PNM leukocytes of 6.3% (P  .01).
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FIGURE 5. Titanium coating of GA-fixed pericardium in group 4 reduced
attraction of polymorphonuclear (PNM) leukocytes to 6.0% (P  .05).
Group 3 was treated with 10% citric acid (CA10%), aldehyde-
dehydrogenase, and physical plasma without titanium. These findings indi-
cate that titanization of blood-contacting surfaces might significantly also
reduce activation and attraction of PNM leukocytes.
Evolving Technology/Basic Science Guldner et al
E
T
/B
SAfter rehydration and swelling of the soft collagen, the
relatively stiff titanium coat breaks, because it is fixed to
the expanding biologic material. It then burst into grooves.
Within the grooves, the collagen seems to be partially cov-
ered with titanium. These surface characteristics might have
important implications regarding the iC3b deposits and
PNM leukocyte attraction (Figure 1,D). Incomplete surface
covering by titanium might contribute to a remaining im-
mune response by apposition of iC3b (Figures 2 and 3).
However, to minimize the immune response, a totally
titanium covered surface would be desirable. This goal
seems achievable if the drying process could be optimized
without shrinking (eg, by cryodrying). Rehydration after
cryodrying might not implicate collagen swelling and thus
no break of the titanium coat (new non published data
support this hypothesis).IC3b Deposits
The IC3b deposits and PMN leukocytes within the con-
trol groups were regarded as 100%. In group 2, iC3b was
increased to 149%  34%, and in group 3, IC3b was
roughly maintained at 102%  24% (P< .22). In group
4, it was significantly reduced to 38.49% (P<.43). The pro-
tection by the titanium coat from IC3b deposits was signif-
icant but not as greater as the protection from PMN
leukocytes, as described below. This might be explainable
by the incomplete coverage of the titanium coat after
hydration.
Hydration causes swelling and re-expansionof the collagen
to its original shape by water incorporation. This expansion1158 The Journal of Thoracic and Cardiovascular Surcauses gaps within the nonswelling titanium coat, demasking
the collagen partially (Figure 1, F), allowing IC3b the
possibility to react and form deposits (Figures 2 and 3).
PMN Leukocytes
The attraction of PMN leukocytes in groups 2 and 3 was
reduced to 89% and 47%, respectively. The titanium-
coated group 4 showed an impressive decrease in PNM leu-
kocytes to 6.3% (P .01). IC3b is able to bind with iC311,
which is located within the cell membrane of the PMN leu-
kocytes.20 It is possible that IC3b can, because of its small
size, reach the collagen in the titanium grooves, but the
PNM leukocytes are too large to become in contact with
collagen and thus initiate an immunoreaction. This might
explain the activation of PNM leukocytes to only 6.3%
(P  .01) in contrast to 38% for IC3b.
Gal-Epitopes and Immune Response
The immune response to xenogen valve prostheses can be
blocked selectively on distinct immunologic-reactive mole-
cules such as the alpha-galactosyl epitope by an anti-Gal
antibody, as previously reported.24,25 However, many
other known and unknown immunologic epitopes are not
influenced by this procedure. Titanization of the valve’s
blood contacting surface with a complete coat, however,
should totally interrupt valve-related immune reactions
and thus prevent valve destruction and enhance the durabil-
ity of biologic GA-fixed heart valve prostheses.
Detoxification by CA10%
CA10% can be used for GA-fixed valve detoxification to
enable partial endothelialization.14 In our study, CA10%
enhanced the immune response of iC3b from 100% to
143% (Figure 3). Thus CA10% should be dismissed for de-
toxification and be replaced by a greater concentration of
aldehyde-dehydrogenase. We expect that, when not using
CA10% for detoxification, the immune response by iC3b
might be decreased to less than 38% after titanization.
Cell Seeding In Vitro and Within Arterial System
Heart valve replacements using autologous tissues are
performed using totally new tissue-engineered valve con-
structs,26,27 cell-seeded scaffolds before implantation,28,29
or self-seeding biologic GA-fixed and titanized heart valve
prostheses.14,15 The grooves within the titanium coat might
partially demask the collagen and prohibit a totally
immunogenicity in the early period after implantation;
however, this rough structure might even be an
advantage because of a good surface structure for cell
adhesion, as already shown in a flow chamber test14 and
for complete cell seeding within the circulation, as previ-
ously described.15 We speculated that after some months,
complete endothelialization might become another excel-
lent protection against activation of the complementgery c May 2012
Guldner et al Evolving Technology/Basic Sciencesystem and adhesion of leukocytes and therefore might be
an additional optimal long-term protection against immune
reactions.Calcification
Calcification of GA-fixed heart valves was understood by
some investigators to be the result of chemical processes
based on free aldehyde groups.4,30 They attempted to
neutralize the free aldehyde groups chemically, but this
procedure was not as successful as expected. Currently,
calcification is assumed to follow the immune response to
the GA-fixed valve matrix by PNM leukocytes mediated
by iC3b.6 Calcification causes valve destruction. The prom-
ising results found in our investigations in vitro must be ver-
ified in chronic animal studies.E
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SCONCLUSIONS
Titanium nanocoating significantly reduced the immuno-
logic response to GA-fixed bovine pericardium in vitro.
However, additional studies in vivo are needed to show
the potential of this new method to prevent destructive im-
munologic processes to the biologic heart valve prostheses
on a long-term basis.
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